Business Description
Control Bionics Ltd
ISIN : AU0000114183
Share Class Description:
ASX:CBL: Ordinary SharesDescription
Control Bionics Ltd is engaged in the business of healthcare devices. It is engaged in the development, commercialization, and sale of assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.63 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.04 | |||||
| Beneish M-Score | -3.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -31.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.51 | |||||
| 9-Day RSI | 56.89 | |||||
| 14-Day RSI | 51.34 | |||||
| 6-1 Month Momentum % | -12.22 | |||||
| 12-1 Month Momentum % | -68.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.34 | |||||
| Quick Ratio | 2.89 | |||||
| Cash Ratio | 1.14 | |||||
| Days Inventory | 187.69 | |||||
| Days Sales Outstanding | 110.63 | |||||
| Days Payable | 182.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.8 | |||||
| Shareholder Yield % | -35.55 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.65 | |||||
| Operating Margin % | -109.43 | |||||
| Net Margin % | -87.26 | |||||
| FCF Margin % | -81.79 | |||||
| ROE % | -58.85 | |||||
| ROA % | -50.44 | |||||
| ROIC % | -88.6 | |||||
| ROC (Joel Greenblatt) % | -198.57 | |||||
| ROCE % | -58.47 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.79 | |||||
| PB Ratio | 0.81 | |||||
| Price-to-Tangible-Book | 1.43 | |||||
| EV-to-EBIT | -1.26 | |||||
| EV-to-EBITDA | -1.41 | |||||
| EV-to-Revenue | 1.11 | |||||
| EV-to-FCF | -1.39 | |||||
| Price-to-Net-Current-Asset-Value | 2.15 | |||||
| Earnings Yield (Greenblatt) % | -79.07 | |||||
| FCF Yield % | -61.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Control Bionics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 5.524 | ||
| EPS (TTM) (A$) | -0.048 | ||
| Beta | 0.73 | ||
| Volatility % | 50 | ||
| 14-Day RSI | 51.34 | ||
| 14-Day ATR (A$) | 0.000868 | ||
| 20-Day SMA (A$) | 0.04135 | ||
| 12-1 Month Momentum % | -68.08 | ||
| 52-Week Range (A$) | 0.033 - 0.144301 | ||
| Shares Outstanding (Mil) | 170.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Control Bionics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Control Bionics Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Control Bionics Ltd Frequently Asked Questions
What is Control Bionics Ltd(ASX:CBL)'s stock price today?
The current price of ASX:CBL is A$0.04. The 52 week high of ASX:CBL is A$0.14 and 52 week low is A$0.03.
When is next earnings date of Control Bionics Ltd(ASX:CBL)?
The next earnings date of Control Bionics Ltd(ASX:CBL) is .
Does Control Bionics Ltd(ASX:CBL) pay dividends? If so, how much?
Control Bionics Ltd(ASX:CBL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers